Warning: array_merge(): Argument #2 is not an array in /home/rarediso/public_html/wp-includes/widgets.php on line 545
Institute for rare diseases » New Rules on Importing Active Pharmaceutical Ingredients
    • Home
    • Activities
    • Rare diseases
    • Registries
    • CAHTA
    • MC RareDis
    • Newsletter
    • About us
  • New Rules on Importing Active Pharmaceutical Ingredients

    Print | Friday 17 August 2012 | 1,962 views

    The European Union has reformed the rules for importing active substances for medicinal products for human use. As of 2 January 2013, all imported active substances must have been manufactured in compliance with standards of good manufacturing practices (GMP) at least equivalent to the GMP of the EU. The manufacturing standards in the EU for active substances are those of the International Conference for Harmonisation – ICH Q7. As of 2 July 2013, this compliance must be confirmed in writing by the competent authority of the exporting country. More information is available on the DG SANCO’s website.

    Copyright © 2018 | IRD - Bulgaria | Term of service | Privacy policy | Advertising policy |